| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |